In 140 men with rising PSA after prostatectomy, PET-guided salvage radiotherapy with dose escalation was associated with 2-year event-free survival of 87% vs 80% in the earlier EMPIRE-1 fluciclovine cohort (p=0.01); fluciclovine vs PSMA-11 PET arms did not differ (87% vs 88%).
RCTn = 140
Jani et al. [18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial